Carl Zeiss Meditec Ag logo

Carl Zeiss Meditec Ag(OTC) CZMWY

Market Cap$3.22BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)+327%
5 Year-80%
1 Year-29%
1 Month+5%
$36.71
-0.22%
-0.08Today
Carl Zeiss Meditec Ag last closing stock price
MetricPriceDate
Last closeUSD 36.792026-10-14
Carl Zeiss Meditec Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+3.34%USD 35.602026-10-07
1 month+4.81%USD 35.102026-09-14
3 month+7.6%USD 34.192026-07-16
Year to date-19.66%USD 45.792025-12-31
1 year-29.21%USD 51.972025-10-14
3 year-52.52%USD 77.492023-10-13
5 year-79.8%USD 182.122021-10-15
Since inception+327.39%USD 8.612008-12-12

Carl Zeiss Meditec Ag Financials at a Glance

Market Cap

$3.22BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€2.66B

Net Income (TTM)

€116.81M

EPS (TTM)

$1.25

P/E Ratio

29.44

Dividend

$0.63

Beta (Volatility)

1.03 (Average)

Price

$36.71

Volume

3,439

Open

$36.99

Previous Close

$36.71

Daily Range

$36.68 - $37.06

52-Week Range

$26.65 - $55.94

Estimated Earnings Date

Dec 10, 2026

CZMWY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Carl Zeiss Meditec Ag

Carl Zeiss Meditec AG is a leading global medical technology company headquartered in Jena, Germany. The firm specializes in ophthalmic devices and microsurgery, providing innovative solutions for healthcare professionals worldwide.

Products and Services
  • Ophthalmic devices for cataract, retinal, and refractive surgeries
  • Advanced visualization tools for microsurgery across various medical disciplines
  • Comprehensive solutions for hospitals and ambulatory surgery centers
Growth Outlook
  • Revenue of €562.7 million in Q3 2026, indicating strong demand
  • Net income of €55.03 million in Q3 2026, reflecting profitability
  • Consistent investment in R&D to drive future innovations
Financial Highlights
  • Trailing twelve months (TTM) revenue of €2.5 billion, showcasing robust performance
  • Net profit margin of 4.4% TTM, indicating effective cost management
  • Dividend yield of 1.78% TTM, appealing for income-focused investors
Carl Zeiss Meditec AG operates in a dynamic healthcare sector, focusing on advanced medical technologies. The company's commitment to innovation is evident in its substantial investment in research and development, which supports its diverse product offerings. Recent financial performance highlights a strong revenue trajectory and profitability, positioning the company favorably for future growth. The consistent demand for its products, particularly in ophthalmology and microsurgery, underscores the potential for sustained revenue generation. With a solid dividend yield, the company may attract investors seeking both growth and income.
AI Generated • Oct 1, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

5,784

CEO

Maximilian Foerst

Website

www.zeiss.de

Headquarters

Jena, TH 07745, DE

CZMWY Financials

Key Financial Metrics (TTM)

Gross Margin

51.04%

Operating Margin

6.42%

Net Income Margin

4.40%

Return on Equity

5.52%

Return on Capital

8.53%

Return on Assets

0.00%

Earnings Yield

3.40%

Dividend Yield

1.71%

Payout Ratio

41.29%

Stock Overview

Market Cap

$3.22BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

87.54M

Volume

3.44K

Avg. Volume

2.68K

Financials (TTM)

Gross Profit

€1.64B

Operating Income

€169.25M

EBITDA

€409.68M

Operating Cash Flow

€298.89M

Capital Expenditure

-€29.19M

Free Cash Flow

€269.59M

Cash & ST Invst.

€23.90M

Total Debt

€0.00

Carl Zeiss Meditec Ag Performance Analysis

Carl Zeiss Meditec Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30EUR 2,057,763,255N/A
20232023-09-30EUR 2,226,938,0108.2%
20242024-09-30EUR 2,239,604,4120.6%
20252025-09-30EUR 2,459,407,1699.8%
Carl Zeiss Meditec Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-3014.2%
Q12025-12-31-25.6%
Q22026-03-31115.1%
Q32026-06-30-44.0%
Carl Zeiss Meditec Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30EUR 3.55N/A
20232023-09-30EUR 3.46-2.6%
20242024-09-30EUR 2.18-37.0%
20252025-09-30EUR 1.78-18.3%
Carl Zeiss Meditec Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-30172.7%
Q12025-12-31-106.7%
Q22026-03-31383.3%
Q32026-06-30276.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

€562.72M

+2.4%

Gross Profit

€302.28M

+4.3%

Gross Margin

53.72%

N/A

Market Cap

$3.22BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$556.79K

N/A

Employees

5,784

N/A

Net Income

€55.03M

+93.9%

EBITDA

€74.87M

+31.2%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

€23.90M

-10.0%

Total Debt

€0.00

N/A

Accounts Receivable

€0.00

N/A

Inventory

€0.00

N/A

Long Term Debt

€0.00

N/A

Short Term Debt

€0.00

N/A

Return on Assets

0.00%

N/A

Return on Invested Capital

0.00%

N/A

Free Cash Flow

€0.00

-100.0%

Operating Cash Flow

€0.00

-100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
STAASTAAR Surgical Company
$22.26+1.92%
BLCOBausch + Lomb Corporation
$16.66+3.87%
SGHTSight Sciences, Inc.
$8.80+6.67%
RXSTRxSight, Inc.
$4.67+3.32%

Trending Stocks

Symbol / CompanyPricePrice Chg
CCCCCC Intelligent Solutions
$7.63-0.13%
INTCIntel
$95.37-2.80%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$107.35-2.89%
CRWVCoreWeave
$69.69+5.94%

Questions About CZMWY

What is the current price of Carl Zeiss Meditec Ag?

Carl Zeiss Meditec Ag is trading at $36.71 per share.

What is the 52-week range for Carl Zeiss Meditec Ag?

Over the past 52 weeks, Carl Zeiss Meditec Ag has traded between $26.65 and $55.94.

How much debt does Carl Zeiss Meditec Ag have?

As of the most recent reporting period, Carl Zeiss Meditec Ag reported total debt of €713.66M.

How much cash does Carl Zeiss Meditec Ag have on hand?

Carl Zeiss Meditec Ag reported €32.04M in cash and cash equivalents in its most recent financial results.

What is Carl Zeiss Meditec Ag’s dividend yield?

Carl Zeiss Meditec Ag currently has a dividend yield of 1.71%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services